Microbix Biosystms ( (TSE:MBX) ) just unveiled an update.
Microbix Biosystems Inc. recently hosted Ontario Premier Doug Ford and MPP Deepak Anand at their Mississauga facilities, highlighting their role as a leading Ontario-based life sciences company. The visit underscored the company’s contributions to healthcare through innovative diagnostic tests that improve patient outcomes and reduce costs. Microbix has benefited from over C$ 2.0 million in grant funding from Ontario’s government, which has supported the development of world-leading healthcare products and reinforced the company’s commitment to maintaining its operations in Ontario.
More about Microbix Biosystms
Microbix Biosystems Inc. is a life sciences company that creates proprietary biological products for human health. It employs over 120 skilled workers and generates sales targeting C$ 2.0 million or more per month. The company manufactures and exports critical ingredients and devices for the global diagnostics industry, including antigens for immunoassays and laboratory quality assessment products (QAPs™). Microbix’s products are available in over 30 countries and the company is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, and Health Canada establishment licensed.
YTD Price Performance: 15.00%
Average Trading Volume: 169,105
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: C$61.86M
For a thorough assessment of MBX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com